Atlas Trials

The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT01032304 · UNKNOWN

Trial details

NCT number
NCT01032304
Sponsor
Edmond Pharma
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease (COPD)
Start date
2009-08-01
Primary completion
2014-03-01
Enrollment
492

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.